News

The selection visit for the study of a new genetically engineered medicine in patients with adult Still's disease was successfully completed. We invite patients for pre-selection!

We invite patients with severe plaque psoriasis to participate in the study of a new genetically engineered drug. The treatment period is 1 year, all examinations and observations are free of charge

A new version of the protocol has been adopted, according to which, in August 2023, the recruitment of patients who have undergone tuberculosis will begin to participate in the study of the GamTBVac vaccine for the prevention of relapse. We invite participants to the preliminary selection. Write to us 8 (993) 202 7840

Permission has been obtained from the Ministry of Health to conduct a new clinical trial of a drug for the treatment of gastroesophageal reflux at the site. We are preparing for the opening!